When
Recent
Daniel Arku
"Examining Risk of Heart Failures With Trastuzumab (Herceptin) Use Among Patients With HER2+ Breast Cancer Using Surveillance, Epidemiology, and End Results (Seer) Medicare: A Retrospective Cohort Study"
Contact Info & Links
Audience
Audience
All